Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Science Translational Medicine
|
June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma
David L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Journal for Immunotherapy of Cancer
|
May 2, 2018
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
Yiwen Li, Carmine Carpenito, George Wang, et al.
Journal for Immunotherapy of Cancer
|
June 6, 2018
Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
Yiwen Li, Carmine Carpenito, George Wang, et al.
Science Translational Medicine
|
May 4, 2012
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells
John Scholler, Troy L Brady, Gwendolyn Binder-Scholl, et al.
Journal for Immunotherapy of Cancer
|
June 6, 2018
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Rikke B Holmgaard, David A Schaer, Yanxia Li, et al.
Cancer Immunology, Immunotherapy : CII
|
December 25, 2012
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors
Emmet McCormack, Katherine J Adams, Namir J Hassan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2013
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside
Cheryl Lai-Lai Chiang, Lana E Kandalaft, Janos Tanyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2016
The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma
Marco Ruella, Saad S Kenderian, Olga Shestova, et al.
Cytotherapy
|
April 7, 2024
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products
Mark D Stewart, Michael Kalos, Vicki Coutinho, et al.
Journal of Translational Medicine
|
March 17, 2012
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
David F Stroncek, Carolina Berger, Martin A Cheever, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Science Translational Medicine
|
June 18, 2010
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma
David L DiGiusto, Amrita Krishnan, Lijing Li, et al.
Journal for Immunotherapy of Cancer
|
May 2, 2018
Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
Yiwen Li, Carmine Carpenito, George Wang, et al.
Journal for Immunotherapy of Cancer
|
June 6, 2018
Correction to: Discovery and preclinical characterization of the antagonist anti-PD-L1 monoclonal antibody LY3300054
Yiwen Li, Carmine Carpenito, George Wang, et al.
Science Translational Medicine
|
May 4, 2012
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells
John Scholler, Troy L Brady, Gwendolyn Binder-Scholl, et al.
Journal for Immunotherapy of Cancer
|
June 6, 2018
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade
Rikke B Holmgaard, David A Schaer, Yanxia Li, et al.
Cancer Immunology, Immunotherapy : CII
|
December 25, 2012
Bi-specific TCR-anti CD3 redirected T-cell targeting of NY-ESO-1- and LAGE-1-positive tumors
Emmet McCormack, Katherine J Adams, Namir J Hassan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2013
A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside
Cheryl Lai-Lai Chiang, Lana E Kandalaft, Janos Tanyi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 29, 2016
The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma
Marco Ruella, Saad S Kenderian, Olga Shestova, et al.
Cytotherapy
|
April 7, 2024
Accelerating the development of genetically engineered cellular therapies: a framework for extrapolating data across related products
Mark D Stewart, Michael Kalos, Vicki Coutinho, et al.
Journal of Translational Medicine
|
March 17, 2012
New directions in cellular therapy of cancer: a summary of the summit on cellular therapy for cancer
David F Stroncek, Carolina Berger, Martin A Cheever, et al.
Page
of 8